Myc rearrangement and gain/amplification in pediatric DLBCL
| Case ID . | Pathologic diagnosis . | Molecular diagnosis by GEP . | Age, y . | Sex . | t(8;14) . | 8q24 CN . | |
|---|---|---|---|---|---|---|---|
| BL vs DLBCL . | DLBCL subgroup . | ||||||
| P01 | DLBCL | DLBCL | GCB | 9 | M | − | 3-4 |
| P02 | DLBCL | DLBCL | GCB | 10 | M | − | 3-5 |
| P03 | DLBCL | DLBCL | GCB | 13 | M | − | 3-4 |
| P04 | DLBCL | DLBCL | GCB | 18 | F | − | ND |
| P05 | DLBCL | DLBCL | PMBL | 15 | F | − | 2 |
| P06 | DLBCL | DLBCL | UC | 11 | M | − | 2 |
| P07 | DLBCL | DLBCL | UC | 18 | M | + | 3-4 |
| P08 | BL | DLBCL | ABC | 2 | M | + | 2 |
| P09 | BL | DLBCL | UC | 11 | F | + | 3 |
| P10 | BL | DLBCL | GCB | 6 | M | + | ND |
| P11 | BL | DLBCL | GCB | 4 | F | + | 2 |
| P12 | BL | DLBCL | GCB | 10 | M | − | 2 |
| P13 | BL | DLBCL | GCB | 10 | F | − | 3-4 |
| P14 | BL | DLBCL | GCB | 2 | M | − | 2 |
| P15 | BL | DLBCL | GCB | 5 | M | − | 3 |
| P16 | BL | DLBCL | GCB | 6 | M | ND | Amplification |
| P17 | BL | DLBCL | GCB | 12 | M | − | ND |
| Case ID . | Pathologic diagnosis . | Molecular diagnosis by GEP . | Age, y . | Sex . | t(8;14) . | 8q24 CN . | |
|---|---|---|---|---|---|---|---|
| BL vs DLBCL . | DLBCL subgroup . | ||||||
| P01 | DLBCL | DLBCL | GCB | 9 | M | − | 3-4 |
| P02 | DLBCL | DLBCL | GCB | 10 | M | − | 3-5 |
| P03 | DLBCL | DLBCL | GCB | 13 | M | − | 3-4 |
| P04 | DLBCL | DLBCL | GCB | 18 | F | − | ND |
| P05 | DLBCL | DLBCL | PMBL | 15 | F | − | 2 |
| P06 | DLBCL | DLBCL | UC | 11 | M | − | 2 |
| P07 | DLBCL | DLBCL | UC | 18 | M | + | 3-4 |
| P08 | BL | DLBCL | ABC | 2 | M | + | 2 |
| P09 | BL | DLBCL | UC | 11 | F | + | 3 |
| P10 | BL | DLBCL | GCB | 6 | M | + | ND |
| P11 | BL | DLBCL | GCB | 4 | F | + | 2 |
| P12 | BL | DLBCL | GCB | 10 | M | − | 2 |
| P13 | BL | DLBCL | GCB | 10 | F | − | 3-4 |
| P14 | BL | DLBCL | GCB | 2 | M | − | 2 |
| P15 | BL | DLBCL | GCB | 5 | M | − | 3 |
| P16 | BL | DLBCL | GCB | 6 | M | ND | Amplification |
| P17 | BL | DLBCL | GCB | 12 | M | − | ND |
The abnormal range for MYC rearrangement is 15%-100%. The abnormal range for MYC amplification is 10%-100%. The abnormal range for multiple copies of 8q24 is 10%-100%.
UC indicates unclassifiable DLBCL; and ND, not determined.